One-Year of Dapaglifozin Add-On Therapy Ameliorates Surrogate Indexes of Insulin Resistance and Adiposity in Patients with Type 2 Diabetes Mellitus
mediaposted on 2021-04-14, 14:47 authored by Adis journals on behalf of, Stefano Radellini, Enrica Vigneri, Valentina Guarnotta, Felicia Panto, Carla Giordano
Article full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.